Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study - Schreiber, I; Buchfelder, M; Droste, M (Eur J Endocrinol, 2007)
et al.